# US 2016/0257936 A1 · Method for Differentiating Pluripotent Stem Cell Induced from Mesenchymal Stem Cell into Chondrocyte

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0257936 A1
- Document ID: US20160257936A1
- Status: Published application
- Kind: A1
- Application number: 15/033,358
- Filed: 2013-11-05
- Published: 2016-09-08
- Earliest claimed: 2013-11-01
- Assignees: Bbhc Co., Ltd.
- Applicants: Bbhc Co., Ltd.
- Inventors: Sang Yeon LEE; Won Ju JUNG; Ho Bin KIM; Min Sun OH; Kye Ho LEE
- Web page: https://patentgrep.com/patent/US20160257936A1

## CPC

- C12N 5/0655: {Chondrocytes; Cartilage}
- A61P 19/00: Drugs for skeletal disorders
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C12N 2500/70: Undefined extracts
- C12N 2500/76: from plants
- C12N 2506/1346: from mesenchymal stem cells
- C12N 2506/1369: from blood-borne mesenchymal stem cells, e.g. MSC from umbilical blood
- C12N 2506/45: from artificially induced pluripotent stem cells
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention relates to a medium composition containing an Ecklonia cava extract for dedifferentiating an induced pluripotent stem cell. Also, the present invention relates to a method for differentiating an induced pluripotent stem cell, produced by using the medium composition into a chondrocyte. When using the medium composition according to the present invention, induced pluripotent stem cells using mesenchymal stem cells can be produced efficiently, and the pluripotent stem cells which have been produced can be useful as a cell treatment agent by being capable of being differentiated into chondrocytes.

## Claims

### Claim 1

A method for differentiating mesenchymal stem cells into chondrocyte, comprising the steps of:
(a) adding an Ecklonia cava extract to a cell culture medium;
(b) dedifferentiating mesenchymal stem cells into induced pluripotent stem cells in the medium; and
(c) differentiating the induced pluripotent stem cells into chondrocytes.

### Claim 2 (depends on 1)

The method of claim 1, wherein the Ecklonia cava extract is added to a medium selected from the group consisting of DMEM (Dulbecco's Modified Eagle's Medium), MEM (Minimal Essential Medium), BME (Basal Medium Eagle), RPM I 1640, F-10, F-12, DMEM-F12, α-MEM (α-Minimal Essential Medium), G-MEM (Glasgow's Minimal Essential Medium), IMDM (Iscove's Modified Dulbecco's Medium), MacCoy's 5A medium, AmnioMax complete Medium, AminoMax II complete Medium, Chang's Medium and MesemCult-XF Medium.

### Claim 3 (depends on 1)

The method of claim 1, wherein the Ecklonia cava extract is added to the medium in an amount of 100-400 μg/ml.

### Claim 4 (depends on 1)

The method of claim 1, wherein the medium further contains 0.01-10 v/v % of energy water.

### Claim 5 (depends on 1)

The method of claim 1, wherein step c) is performed by using a medium containing dexamethason, Acetylsalicylic acid (AsA), sodium pyruvate, proline, Insulin-Transferrin-Selenium (ITS) and TGF.

### Claim 6 (depends on 5)

The method of claim 5, wherein the medium contains 3-isobutyl-1-methylxanthine, hydrocortisone and indomethacin in a medium selected from the group consisting of DMEM (Dulbecco's Modified Eagle's Medium), MEM (Minimal Essential Medium), BME (Basal Medium Eagle), RPM I 1640, F-10, F-12, DMEM-F12, α-MEM (α-Minimal Essential Medium), G-MEM (Glasgow's Minimal Essential Medium), IMDM (Iscove's Modified Dulbecco's Medium), MacCoy's 5A medium, AmnioMax complete Medium, AminoMax II complete Medium, Chang's Medium and MesemCult-XF Medium.

### Claim 7 (depends on 1)

Chondrocytes produced by the method of claim 1.

### Claim 8 (depends on 7)

A cell therapy composition comprising the chondrocytes of claim 7.

### Claim 9

A medium composition comprising an Ecklonia cava extract for dedifferentiating mesenchymal stem cells into induced pluripotency stem cells, characterized by the induced pluripotency stem cells are capable of differentiating into chondrocytes.
